Active Biotech et Ipsen signent un partenariat d’envergure pour le co-développement et la commercialisation de TASQ en uro-oncologie

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021